Aetna negotiates Hepatitis C treatment discount with Gilead

January 17, 2015 1:00 AM

13 0

American health insurer Aetna on Friday announced that it had reached a deal with Gilead Sciences for its hepatitis C treatment and negotiated a discount for the medicine.

America's third-largest insurer said it would offer the treatment as the preferred choice to its nearly 11 million commercial customers.

Read more

To category page